• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期皮质激素治疗对慢性活动性肝病免疫紊乱的影响。

Influencing immune perturbations by prolonged corticotherapy in the chronic active liver disease.

作者信息

Banciu T, Arcan P, Stroe A

出版信息

Med Interne. 1985 Jul-Sep;23(3):177-83.

PMID:4048798
Abstract

This paper deals with the influencing of the imbalance of humoral and cellular immunity in chronic active liver disease (CALD) due to prolonged administration of continuous corticotherapy in moderate doses. This paper presents a controlled study carried out in 30 patients with CALD of whom 15 received corticotherapy, while the other 15 only a conventional hepatotropic treatment for a year. The results obtained show, beside a clinical and biological improvement, a positive influence on the immune parameters with a tendency of restoration of immune homeostasis, i.e., an increase of the T total and T1 (suppressing/cytotoxic) lymphocytes in the peripheral blood, with the concomitant decrease of IgG, IgM and circulating immune complexes (CIC). In the control group the changes were insignificant, but sometimes an aggravation of the immune disturbances could be observed. This study confirms the favourable effect of prolonged corticotherapy in CALD and argues for its immune-modulating action.

摘要

本文探讨了中度剂量持续皮质激素治疗时间过长对慢性活动性肝病(CALD)体液免疫和细胞免疫失衡的影响。本文介绍了一项对照研究,该研究对30例CALD患者进行,其中15例接受皮质激素治疗,另外15例仅接受常规保肝治疗,为期一年。获得的结果显示,除了临床和生物学改善外,对免疫参数有积极影响,具有免疫稳态恢复的趋势,即外周血中T总淋巴细胞和T1(抑制/细胞毒性)淋巴细胞增加,同时IgG、IgM和循环免疫复合物(CIC)减少。在对照组中,变化不显著,但有时可观察到免疫紊乱加重。本研究证实了长期皮质激素治疗对CALD的有利作用,并支持其免疫调节作用。

相似文献

1
Influencing immune perturbations by prolonged corticotherapy in the chronic active liver disease.长期皮质激素治疗对慢性活动性肝病免疫紊乱的影响。
Med Interne. 1985 Jul-Sep;23(3):177-83.
2
Variations in humoral and cellular immunologic changes in relation to the evolutive stage of chronic active liver disease.与慢性活动性肝病演变阶段相关的体液和细胞免疫变化
Med Interne. 1987 Jan-Mar;25(1):25-30.
3
Circulating immune complexes in chronic hepatitis as related to the presence of HBsAg.
Med Interne. 1984 Jan-Mar;22(1):61-5.
4
[The immune compartment in chronic active liver disease responsive and non-responsive to corticoid therapy].[对皮质类固醇治疗有反应和无反应的慢性活动性肝病中的免疫区室]
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1987 Jan-Mar;39(1):91-5.
5
Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.慢性活动性肝病中的细胞免疫和体液免疫反应。I. 未经治疗的特发性自身免疫性肝炎、慢性乙型活动性肝炎和原发性胆汁性肝硬化患者肝活检中的淋巴细胞亚群。
Clin Exp Immunol. 1982 Oct;50(1):17-24.
6
[Evaluation of clinical effectiveness of colchicine in the treatment of chronic active hepatitis with transformation to liver cirrhosis].[秋水仙碱治疗慢性活动性肝炎并转化为肝硬化的临床疗效评估]
Przegl Epidemiol. 1991;45(4):331-4.
7
Effectiveness of thymostimulin treatment in hepatitis B surface antigen-positive chronic active liver disease. Results of a randomized clinical trial.胸腺刺激素治疗乙肝表面抗原阳性慢性活动性肝病的疗效。一项随机临床试验的结果。
Arzneimittelforschung. 1985;35(8):1317-22.
8
Loss of suppressor T cell function and circulating immune complexes in chronic active liver diseases.慢性活动性肝病中抑制性T细胞功能丧失及循环免疫复合物
Clin Exp Immunol. 1981 Nov;46(2):375-81.
9
Immunological studies in HBV-related chronic liver diseases.乙型肝炎病毒相关慢性肝病的免疫学研究
Indian J Pathol Microbiol. 1990 Oct;33(4):351-4.
10
The interference of an autoimmune mechanism in the pathogeny of chronic active liver diseases.自身免疫机制在慢性活动性肝病发病机制中的干扰作用。
Med Interne. 1989 Jan-Mar;27(1):47-52.

引用本文的文献

1
Antibody dependent cytotoxicity in chronic active liver disease.
Gastroenterol Jpn. 1988 Dec;23(6):695-7. doi: 10.1007/BF02782958.